Navigation Links
BioMarin Announces Second Quarter 2011 Financial Results
Date:7/28/2011

ing of BioMarin's clinical trials of GALNS, Firdapse, PEG-PAL, BMN-673 , BMN-701 and other product candidates; the continued clinical development and commercialization of Aldurazyme, Naglazyme, Kuvan, Firdapse, and its product candidates; and actions by regulatory authorities. These forward-looking statements are predictions and involve risks and uncertainties such that actual results may differ materially from these statements. These risks and uncertainties include, among others: our success in the continued commercialization of Naglazyme, Kuvan, and Firdapse; Genzyme Corporation's success in continuing the commercialization of Aldurazyme; results and timing of current and planned preclinical studies and clinical trials, particularly with respect to GALNS, Firdapse, PEG-PAL, BMN 673 and BMN 701; our ability to successfully manufacture our products and product candidates; the content and timing of decisions by the U.S. Food and Drug Administration, the European Commission and other regulatory authorities concerning each of the described products and product candidates; the market for each of these products and particularly Aldurazyme, Naglazyme, Kuvan and Firdapse; actual sales of Aldurazyme, Naglazyme Kuvan and Firdapse; Merck Serono's activities related to Kuvan; and those factors detailed in BioMarin's filings with the Securities and Exchange Commission, including, without limitation, the factors contained under the caption "Risk Factors" in BioMarin's 2010 Annual Report on Form 10-K, and the factors contained in BioMarin's reports on Form 10-Q. Stockholders are urged not to place undue reliance on forward-looking statements, which speak only as of the date hereof. BioMarin is under no obligation, and expressly disclaims any obligation to update or alter any forward-looking statement, whether as a result of new information, future events or otherwise.

BioMarin®, Naglazyme®, Kuvan® and Firdapse™ are registered trademarks of BioMarin Pha
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
2. BioMarin Announces FDA Approval for Kuvan
3. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
4. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
5. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
6. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
7. BioMarin Acquires Huxley Pharmaceuticals, Inc.
8. BioMarin to Present at the Oppenheimer Healthcare Conference
9. BioMarin Announces Third Quarter 2009 Financial Results
10. BioMarin to Acquire LEAD Therapeutics
11. BioMarin to Present at the Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... 2015  IRIDEX Corporation (NASDAQ: IRIX ) today ... financial results after the market closes on Thursday, ... the Company will host a conference call with the ... Thursday, May 7, 2015 to discuss ... Interested parties may access the live conference ...
(Date:4/30/2015)... , April 30, 2015  Cumberland Pharmaceuticals Inc. ... release first quarter 2015 financial results after the market ... and live Internet webcast will be held on Thursday, ... discuss the results. To participate in the ... (for international callers).  A rebroadcast of the teleconference will ...
(Date:4/30/2015)... 30, 2015 Perrigo Company plc (NYSE: PRGO ; ... C. Papa will present at the 2015 Deutsche Bank 40 ... 6, 2015 at the InterContinental Hotel in Boston ... Chairman, President and CEO Joseph C. Papa will present ... 1:00PM PT on Tuesday, May 12, 2015 at the Encore at ...
Breaking Medicine Technology:IRIDEX Announces First Quarter 2015 Conference Call and Release Date 2Cumberland Pharmaceuticals To Announce First Quarter 2015 Financial Results 2Perrigo Company To Present At Upcoming Healthcare Conferences 2Perrigo Company To Present At Upcoming Healthcare Conferences 3
... , HOUSTON , Feb. ... "Frank" De Santiago. On January 29 , De Santiago ... at Texas Children,s Heart Center . De Santiago made ... discharged from a pediatric hospital with an implanted mechanical heart ...
... , WASHINGTON , Feb. 12 ... President Bill Clinton a quick recovery following his ... patients, Mr. Clinton has communicated a desire to return to ... surgery to open the chest, most patients who receive coronary ...
Cached Medicine Technology:Texas Children's Hospital Discharges History-Making Teen Patient Again; This Time With a Transplanted Heart Replacing Mechanical Device 2Texas Children's Hospital Discharges History-Making Teen Patient Again; This Time With a Transplanted Heart Replacing Mechanical Device 3SCAI Statement on the Hospitalization of Former President Bill Clinton 2
(Date:5/3/2015)... “ BolehVPN ” was featured on NewsWatch ... latest and coolest technology products available to consumers. Scott Steinberg, ... review and shared with viewers how to protect their private ... is on computers and even more so online. It helps ... all over the world. In terms of work, the internet ...
(Date:5/3/2015)... 03, 2015 It is not too late to ... Walk in Memory of Lissa Anne Been in Arnold, Missouri ... great family-friendly event to honor her loving memory. It has benefited ... , Just having turned 37, Lissa suffered a brain aneurysm ... August 24, 2012. This event is designed to serve as a ...
(Date:5/2/2015)... 2015 Vancouver fencing company, QS Fencing, has ... advice to prospective clients related to their questions on railings ... railings around their decks and patios. While that seems like ... up once the person rolls up their sleeve to start ... railing in finding a gate that matches it. , Instead ...
(Date:5/2/2015)... We are pleased to announce the ... as one of the Top Workplaces of 2015. , ... treatment field for their ethics and standards of excellence. ... continue their educational efforts. The Delray Recovery Center prides ... their purpose – to help individuals heal from the ...
(Date:5/2/2015)... 2015 As a nonsurgical staple ... the face, neck and décolleté, radiofrequency energy is ... potential for the success of vulvovaginal rejuvenation. In ... Advisory Council, ThermiGyn’s Women’s Health Clinical Advisory Board ... that ThermiGyn’s temperature controlled radio frequency, specifically that ...
Breaking Medicine News(10 mins):Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:The Delray Recovery Center Named 2015 Top Workplace 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3
... Pharmaceuticals Inc. today,announced the appointment of Anthony "Tony" ... the recently initiated Phase 2 clinical trial of,CTS-1027 ... assisting in the,development of the longer-term clinical development ... more than 20 years in the,industry. Previous industrial ...
... Massey Cancer Center will open a Phase I ... with leading researchers from Israel, marking the first ... their counterparts in Israel. , The study ... U.S.-Israel Bi-National Industrial Research and Development Foundation (BIRDF). ...
... A free white paper is helping,building owners ... can result when they,re forced by the construction,schedule ... "system final,completion.", "There,s a disturbing trend in ... after occupancy," says Mike Della Barba,Director of Commissioning ...
... Social Security at http://www.nasi.org , WASHINGTON, March ... to comment on the implications of the,2008 Social Security ... listed below are members of the National Academy,of Social ... up of the nation,s leading,experts on Social Security, Medicare, ...
... Healthy,Coffee USA, Inc., the marketing arm of ... that Jim Clayton, a multi-level,marketing expert and start-up ... consultant. Mr. Clayton brings to the company a ... Clayton is a,start-up specialist who has been engaged ...
... of dying increased for patients with the common condition, ... Older people with heart failure face heightened odds of ... largest study ever conducted on the issue. , "We,re ... lead researcher Dr. Adrian F. Hernandez, an assistant professor ...
Cached Medicine News:Health News:Conatus Pharmaceuticals Appoints Anthony W. Fox, MD, Ph.D., as Chief Medical Officer 2Health News:VCU Massey Cancer Center to partner with Israeli biotech firm 2Health News:VCU Massey Cancer Center to partner with Israeli biotech firm 3Health News:White Paper Helps Building Owners Avoid Costs, Downfalls of Construction Projects 2Health News:NASI Experts Available to Comment on 2008 Social Security and Medicare Trustees Reports 2Health News:NASI Experts Available to Comment on 2008 Social Security and Medicare Trustees Reports 3Health News:MLM Expert and Start-Up Specialist Jim Clayton Joins Healthy Coffee USA 2Health News:MLM Expert and Start-Up Specialist Jim Clayton Joins Healthy Coffee USA 3Health News:Heart Failure Raises Risks After Non-Cardiac Surgeries 2Health News:Heart Failure Raises Risks After Non-Cardiac Surgeries 3
An economical solution to the need to provide wrap-around protection. The one-sided velcro closure allows greater flexibility in sizing. Front protection is 0.5mm Pb and the back is 0.25mm Pb equival...
This wrap around apron features a uniquely designed orthopedic wide belt that is integrated directly on the apron....
The most comfortable and easy to use apron in the industry. This front protection apron comes with a fully adjustable snap-on 5" orthopedic belt to relieve weight off your shoulders. Velcro strap acr...
Unique criss-cross strapping. The MSV-10 is our most popular model. Extra wide Velcro ensures a wide variety of adjustments and easy closing....
Medicine Products: